Wells Fargo’s VistaGen Therapeutics VTGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-211
| Closed | -$1.11K | – | 7016 |
|
|
2024
Q1 | $1.11K | Buy |
211
+3
| +1% | +$16 | ﹤0.01% | 5736 |
|
|
2023
Q4 | $1.07K | Buy |
208
+140
| +206% | +$720 | ﹤0.01% | 5763 |
|
|
2023
Q3 | $356 | Buy |
68
+28
| +70% | +$147 | ﹤0.01% | 6061 |
|
|
2023
Q2 | $75 | Sell |
40
-141,527
| -100% | -$265K | ﹤0.01% | 6633 |
|
|
2023
Q1 | $17.7K | Buy |
141,567
+39,067
| +38% | +$4.87K | ﹤0.01% | 5365 |
|
|
2022
Q4 | $10.6K | Buy |
102,500
+25,309
| +33% | +$2.61K | ﹤0.01% | 5210 |
|
|
2022
Q3 | $11K | Sell |
77,191
-2,382
| -3% | -$339 | ﹤0.01% | 5333 |
|
|
2022
Q2 | $70K | Sell |
79,573
-38,065
| -32% | -$33.5K | ﹤0.01% | 4590 |
|
|
2022
Q1 | $145K | Sell |
117,638
-65,073
| -36% | -$80.2K | ﹤0.01% | 4835 |
|
|
2021
Q4 | $356K | Buy |
182,711
+96,757
| +113% | +$189K | ﹤0.01% | 4596 |
|
|
2021
Q3 | $235K | Buy |
+85,954
| New | +$235K | ﹤0.01% | 4747 |
|
|
2021
Q2 | – | Sell |
-863
| Closed | -$2K | – | 7078 |
|
|
2021
Q1 | $2K | Buy |
863
+442
| +105% | +$1.02K | ﹤0.01% | 6276 |
|
|
2020
Q4 | $1K | Hold |
421
| – | – | ﹤0.01% | 6041 |
|
|
2020
Q3 | $0 | Buy |
421
+121
| +40% | – | ﹤0.01% | 6552 |
|
|
2020
Q2 | $0 | Buy |
300
+2
| +0.7% | – | ﹤0.01% | 6456 |
|
|
2020
Q1 | $0 | Sell |
298
-149,702
| -100% | – | ﹤0.01% | 6422 |
|
|
2019
Q4 | $103K | Hold |
150,000
| – | – | ﹤0.01% | 5077 |
|
|
2019
Q3 | $161K | Buy |
150,000
+106,700
| +246% | +$115K | ﹤0.01% | 4886 |
|
|
2019
Q2 | $31K | Buy |
+43,300
| New | +$31K | ﹤0.01% | 5362 |
|